These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6381284)

  • 21. Immunoperoxidase localization of prostatic antigens. Comparison of primary and metastatic sites.
    Stein BS; Vangore S; Petersen RO
    Urology; 1984 Aug; 24(2):146-52. PubMed ID: 6205496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate cancer-associated markers.
    Chu TM
    Immunol Ser; 1990; 53():339-56. PubMed ID: 1713065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fine needle aspiration cytology of prostatic adenocarcinoma metastatic to the lung confirmed by the immunoperoxidase technique.
    Bartziota EV
    Acta Cytol; 1986; 30(5):497-500. PubMed ID: 2430390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Papillary adenocarcinomas of the prostate. An immunohistochemical study.
    Kuhajda FP; Gipson T; Mendelsohn G
    Cancer; 1984 Oct; 54(7):1328-32. PubMed ID: 6205741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoperoxidase staining of acid phosphatase in human prostatic tissue.
    Lippert MC; Bensimon H; Javadpour N
    J Urol; 1982 Nov; 128(5):1114-6. PubMed ID: 6757466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate specific antigen: not detectable despite tumor progression after radical prostatectomy.
    Goldrath DE; Messing EM
    J Urol; 1989 Oct; 142(4):1082-4. PubMed ID: 2477560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunohistochemical diagnosis of metastasizing prostatic carcinomas].
    Friedmann W; Steffens J; Lobeck H
    Onkologie; 1984 Dec; 7(6):337-41. PubMed ID: 6084838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carcinoma of the prostate with atypical immunohistological features. Clinical and histologic correlates.
    Feiner HD; Gonzalez R
    Am J Surg Pathol; 1986 Nov; 10(11):765-70. PubMed ID: 2430476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-treatment and post-treatment evaluation of prostatic adenocarcinoma for prostatic specific acid phosphatase and prostatic specific antigen by immunohistochemistry.
    Vernon SE; Williams WD
    J Urol; 1983 Jul; 130(1):95-8. PubMed ID: 6191050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical demonstration of tumor-associated antigens in prostatic carcinomas of various histological differentiations.
    Friedmann W; Steffens J; Lobeck H; Blümcke S; Nagel R
    Eur Urol; 1985; 11(1):52-6. PubMed ID: 2580711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small cell carcinoma of the prostate. II. Immunohistochemical and electron microscopic studies of 18 cases.
    Ro JY; Têtu B; Ayala AG; Ordóñez NG
    Cancer; 1987 Mar; 59(5):977-82. PubMed ID: 2434204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of fixation effects on immunohistochemical localization of prostatic specific antigen in human prostate.
    Sinha AA; Hagen KA; Sibley RK; Wilson MJ; Limas C; Reddy PK; Blackard CE; Gleason DF
    J Urol; 1986 Sep; 136(3):722-7. PubMed ID: 2426478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.
    Jack GS; Brash AR; Olson SJ; Manning S; Coffey CS; Smith JA; Shappell SB
    Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostatic origin of metastases: immunoperoxidase localization of prostate-specific antigen.
    Ghazizadeh M; Kagawa S; Maebayashi K; Izumi K; Kurokawa K
    Urol Int; 1984; 39(1):9-12. PubMed ID: 6203202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens.
    Gallee MP; Visser-de Jong E; van der Korput JA; van der Kwast TH; ten Kate FJ; Schroeder FH; Trapman J
    Urol Res; 1990; 18(3):181-7. PubMed ID: 1697709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical identification of prostatic acid phosphatase: correlation of tumor grade with acid phosphatase distribution.
    Bates RJ; Chapman CM; Prout GR; Lin CW
    J Urol; 1982 Mar; 127(3):574-80. PubMed ID: 6174741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical prostatic acid phosphatase level as a prognostic factor of prostatic carcinoma.
    Sakai H; Shiraishi K; Minami Y; Yushita Y; Kanetake H; Saito Y
    Prostate; 1991; 19(3):265-72. PubMed ID: 1946042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucinous adenocarcinoma of the prostate gland.
    Epstein JI; Lieberman PH
    Am J Surg Pathol; 1985 Apr; 9(4):299-308. PubMed ID: 2409826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoperoxidase localization of prostate-specific antigen.
    Stein BS; Vangore S; Petersen RO; Kendall AR
    Am J Surg Pathol; 1982 Sep; 6(6):553-7. PubMed ID: 6183983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study on expression of prostatic inhibin peptide, prostate acid phosphatase and prostate specific antigen in androgen independent human and rat prostate carcinoma cell lines.
    Garde SV; Sheth AR; Porter AT; Pienta KJ
    Cancer Lett; 1993 Jul; 70(3):159-66. PubMed ID: 7689036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.